Product Information
IBSRELA 50 MG TABLET is a brand product labeled by Ardelyx, Inc., priced at $32.5579 per EA under NDC 73154005060. Its NADAC has been published 171 times since Mar 22, 2023.
Strength
53.2 mg/1
Manufacturer
Ardelyx, Inc.NDC
73154005060
Classification
Brand
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
TENAPANOR HYDROCHLORIDEApproval Type
New Drug (NDA)
FDA Application
NDA211801On Market Since
9/12/2019
Pharmacological Classes
Price Statistics
The NADAC for IBSRELA 50 MG TABLET has been published 171 times since Mar 22, 2023, and over the history we have for it it has risen 20.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $32.5579 per EA |
|---|---|
| All-time high | $32.5863 (May 13, 2026) |
| All-time low | $27.1191 (Mar 22, 2023) |
| 52-week high | $32.5863 |
| 52-week low | $29.8890 |
| Median price | $28.6067 |
| Average price | $29.2028 |
| Largest weekly change | +9.0% (Jan 14, 2026) |
| Weeks tracked | 171 |
| Tracking since | Mar 22, 2023 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the tenapanor hydrochloride market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of IBSRELA 50 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for IBSRELA 50 MG TABLET, manufactured by Ardelyx, Inc., is $32.5579 per EA (NDC 73154005060), effective Jun 24, 2026.
How has the price of IBSRELA 50 MG TABLET changed over time?
Over the history we have for it, the NADAC for IBSRELA 50 MG TABLET has risen 20.1%. It has been tracked across 171 weekly CMS publications since Mar 22, 2023.
What are the highest and lowest recorded NADAC prices for IBSRELA 50 MG TABLET?
Since Mar 22, 2023, the NADAC for IBSRELA 50 MG TABLET has ranged from a low of $27.1191 (Mar 22, 2023) to a high of $32.5863 (May 13, 2026), with a median of $28.6067 per EA.
Are there cheaper alternatives to IBSRELA 50 MG TABLET?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of IBSRELA 50 MG TABLET, so no direct lower-cost alternative is listed.
Who manufactures IBSRELA 50 MG TABLET?
IBSRELA 50 MG TABLET (NDC 73154005060) is labeled by Ardelyx, Inc., and CMS classifies it as a brand product.